Status:
COMPLETED
Effect of a New HA Filler in Correcting Nasolabial Fold
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Aging Problems
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
The investigators aimed to evaluate the efficacy and safety of new HA filler for nasolabial fold correction
Detailed Description
A 24-week prospective, single-center, assessor-blinded, randomized, split-face study was conducted to compare the clinical efficacy and safety of new HA filler versus Juvederm for nasolabial fold corr...
Eligibility Criteria
Inclusion
- Patients who had prominent NLFs with a WSRS score of 3 or 4 on both sides
Exclusion
- patients with active facial skin diseases or history of severe allergies, autoimmune disorders, or hypersensitivity to HA or any of the excipients contained in the investigational filler
- participants who had used a local topical preparation (steroid and retinoid) within 2 weeks before the study
- participants who had undergone chemical peeling, laser procedures, or acne treatments within 4 months before the study
- participants who had been injected with other biomaterials, including HA within 6 months before the study.
Key Trial Info
Start Date :
October 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 8 2023
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT06574750
Start Date
October 16 2021
End Date
May 8 2023
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam, South Korea, 13620